financetom
Business
financetom
/
Business
/
US approves offshore wind project off Maryland coast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US approves offshore wind project off Maryland coast
Sep 5, 2024 6:33 AM

Sept 5 (Reuters) - President Joe Biden's administration

on Thursday announced final approval of a wind project off the

coast of Maryland, bringing the U.S. halfway to its goal of

deploying 30 gigawatts of the clean energy technology by 2030.

The project is the 10th approved by Biden's Interior

Department. He has made offshore wind a cornerstone of his

climate change agenda.

The Maryland Offshore Wind Project, which is being developed

by US Wind, could one day generate enough electricity to power

718,000 homes, Interior said in a statement. The lease area is

about 9 nautical miles off the coasts of Maryland and Delaware.

US Wind is a subsidiary of Renexia SpA, the renewable

development arm of Italian infrastructure firm Toto Holding.

Interior and White House officials celebrated the milestone

of permitting 15 gigawatts of offshore wind, half the capacity

the administration in 2021 said it wanted to have in the water

by 2030.

Few in the industry expect that goal to be met, citing a

flurry of setbacks including soaring costs and supply chain

disruptions that have led to project delays and cancellations.

"We never thought this exercise would be easy or smooth

sailing," Liz Klein, director of the Bureau of Ocean Energy

Management, said on a call with reporters, adding the

administration would keep working toward its goal.

The project will have 114 wind turbines and is expected to

be brought online in phases.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
XPeng Shares Are Trading Higher: What's Going On?
XPeng Shares Are Trading Higher: What's Going On?
Dec 2, 2024
XPeng Inc ( XPEV ) shares are trading higher on Monday. The company provided a vehicle delivery update for November over the weekend. Here’s a look at what you need to know. What To Know: XPeng ( XPEV ) announced Sunday that it delivered 30,895 EVs in November, up 54% year-over-year, and 29% on a month-over-month basis. The company has...
Tesla Readies to Launch App for Apple Watch
Tesla Readies to Launch App for Apple Watch
Dec 2, 2024
12:12 PM EST, 12/02/2024 (MT Newswires) -- Tesla (TSLA) said in a Twitter post on Monday that it is launching a Tesla App for Apple's ( AAPL ) Apple Watch next week, which provides phone key access to vehicles. The app will allow users to see battery charge, open the frunk and turn on climate control, according to Tesla. The...
Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says
Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says
Dec 2, 2024
12:16 PM EST, 12/02/2024 (MT Newswires) -- Applied Therapeutics ( APLT ) faces uncertainty after the US Food and Drug Administration rejected the company's new drug application for its drug candidate govorestat in classic galactosemia, a genetic metabolic disorder, due to deficiencies in the clinical application, UBS Securities said in a report Monday. The company disclosed last week the health...
Update: NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint
Update: NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint
Dec 2, 2024
12:09 PM EST, 12/02/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.) NovoCure's ( NVCR ) shares rose more than 41% in recent Monday trading after the company and Zai Lab ( ZLAB ) said that their phase 3 trial evaluating TTFields along with gemcitabine and nab-paclitaxel as a treatment for unresectable, locally advanced pancreatic...
Copyright 2023-2025 - www.financetom.com All Rights Reserved